Chief Medical Officer (6) · Adicet Bio, Inc. (ACET)

Julia Maltzman

FY2025 is the first fiscal year CompBrief holds for Julia Maltzman as a named executive officer of Adicet Bio; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,124,803

Salary $452,308Stock awards $0

2nd of 3 named executive officers at Adicet Bio by FY2025 total.

3 named officers on file for Adicet Bio, FY2025

Julia Maltzman’s pay file — $29

  • 1 fiscal year of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Adicet Bio’s whole pay program stands against its peers

  • Adicet Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ACET→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2026 (DEF 14A).

Free

Get Julia Maltzman’s full pay file as a PDF — free

More than this page: up to 10 years of Julia’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Julia Maltzman compensation by year

Adicet Bio Summary Compensation Table · the one fiscal year held
In US dollars, as Adicet Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$452,308
Bonus$0
Stock awards$0
Option awards$502,605
Non-equity incentive$153,600
Pension and deferred compensation$0
All other$16,290
Total$1,124,803

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Adicet Bio, Inc. DEF 14A filed April 29, 2026, accession 0001720580-26-000027, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Adicet Bio, Inc. filed document, accession 0001720580-26-000027. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
Option35,156—$14.24

Per the Outstanding Equity Awards at Fiscal Year-End table in Adicet Bio, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Adicet Bio’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Chen SchorPresident and Chief Executive Officer$1,465,747
Julia Maltzman · this pageChief Medical Officer (6)$1,124,803
Blake AftabChief Scientific Officer and Senior Vice President$915,489

The full Adicet Bio compensation record

free company brief

This page is one person within Adicet Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Adicet Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Julia Maltzman's compensation dossier · One-time report. No refunds.